
[摘要] 目的 探究腦卒中后吞咽障礙患者采用針刺結合吞咽訓練的治療效果以及吞咽功能恢復情況。方法 隨機選取該院2014年2月—2016年10月收治腦卒中后吞咽障礙患者100例作為研究對象,根據治療方式分為結合組和參照組,每組50例。結合組給予針刺結合吞咽訓練治療,參照組僅采用吞咽訓練治療,觀察兩組患者治療效果。結果研究結果顯示結合組總治療有效率為88.00%優于參照組66.00%,且結合組洼田氏飲水試驗評價量表和藤島一郎吞咽評價標準評分優于參照組,對比顯示差異有統計學意義(P<0.05)。 結論 針刺結合吞咽訓練治療比單獨的吞咽訓練療效更好,可提升患者吞咽功能,值得臨床推廣應用。
[關鍵詞] 針刺;吞咽訓練;腦卒中;吞咽障礙
[中圖分類號] R49 [文獻標識碼] A [文章編號] 1674-0742(2016)12(c)-0174-03
[Abstract] Objective To Explore the Therapeutic Effect of Swallowing Training Combined with Acupuncture in the Treatment of Patients with Dysphagia after Stroke and the Recovery of Swallowing Function. Methods Random selection 100 patients with dysphagia after stroke in our hospital from February 2014 to October 2016 were selected as the research objects. According to the treatment methods,all of the 100 patients were divided into the combined group and the reference group , each with 50 cases. The combined group was given the combined treatment of acupuncture and swallowing training, and the reference group was only treated with the swallowing training so as to observe the therapeutic effect on patients in two groups. Results The results showed that the effective rate in the combined group was 88.00%, which was superior to 66.00% in the reference group. Besides, the Kubota drinking water test evaluation questionnaire and cany island ichiro swallowing evaluation standard score in the combined group were higher than those in the reference group. The comparison was of statistical significance(P< 0.05). Conclusion It’s worthy of clinical application and promotion ,for the combined treatment of acupuncture and swallowing training is better than that of the sole swallowing training and it can promote the swallowing function of patients.
[Key words] Acupuncture; Swallow Training; Stroke; Dysphagia
據統計,全國近一半腦卒中患者有吞咽功能障礙。吞咽功能障礙主要表現為誤吸、嗆咳等,嚴重會發展為肺炎,甚至死亡[1]。目前,臨床對該疾病治療多采用現代吞咽康復訓練方式為主,但國內部分學者認為腦卒中后吞咽障礙可結合中醫治療[2]。但因吞咽障礙患者難以口服中藥,因此中醫治療以針刺為主。為探究針刺結合吞咽訓練對腦卒中后吞咽障礙患者的治療效果,現隨機選取該院2014年2月—2016年10月收治的100例腦卒中后具有吞咽障礙患者作為研究對象,現報道如下。
1 資料與方法
1.1 一般資料
隨機選取該院收治的腦卒中后吞咽障礙患者100例作為研究對象,根據治療方式分為結合組50例和參照組50例。……